questionText: To ask the Secretary of State for Health and Social Care, with reference to the National Patient Safety Alert entitled Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets,
answerText: We are aware of disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD), primarily driven by issues which have resulted in capacity constraints at key manufacturing sites.The National Patient Safet...
heading: Methylphenidate: Shortages